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Abstract
Background
Th1 cells play an essential role in immune protection against tuberculosis. Th17 cells might
be involved with immune pathology in active human tuberculosis (TB). The balance be-
tween Th1 and Th17 cells in patients with cavitary tuberculosis needs to be clarified which
might help understanding the immunological basis of pathologic pathogenesis in TB.
Method
Initially treated pulmonary TB (PTB) patients with or without cavities were recruited before
chemotherapy. We isolated peripheral blood mononuclear cells, stimulated with phytohe-
magglutinin (PHA), PPD, or ESAT-6 antigens, and assayed supernatant IFN-γ and IL-17 by
ELISA after 24 or 72 hours incubation, respectively. Cells were also stained with antibodies
to CD3, CD4, CD8, IFN-γ or IL-17 and the proportion of stained cells was measured by
flow cytometry.
Results
We found wide variation of IFN-γ response in active PTB patients, but less subject-to-sub-
ject variation of IL-17 was observed as we previously reported. There were no significant dif-
ferences in IFN-γ and IL-17 between cavitary and non-cavitary PTB; however, we found
decreased IFN-γ secretion in severe cavitary PTB compared to mild lesion non-cavitary
PTB (p < 0.05). We also found a decrease in the proportion of CD3+CD4+ T cells in the
blood of severe cavitary PTB patients (p < 0.05).
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Conclusions
IL-17 seemed to have no association with the formation of cavities in active PTB from the
study of PBMC. Impaired IFN-γ without IL-17 enhancement occurs in peripheral blood dur-
ing severe cavitary PTB. Our results demonstrate thatM. tuberculosis antigen-specific Th1
response is decreased when PTB lesions develop to severe cavities.
Introduction
Tuberculosis (TB) ranks as the second leading cause of death from the infectious diseases
worldwide, there were 8.6 million new TB cases in 2012 as reported [1]. The bacterium can re-
main latent in the host, turn into active TB, or the pathogens can be eradicated through the in-
teraction of the host’s immune system withM. tuberculosis [2]. Adaptive immune responses
mediated by CD4+ T cells play a critical role in controlling the progress ofM. tuberculosis in-
fection, as HIV/AIDS patients whose CD4+ T cells are deficient are more susceptible toM. tu-
berculosis(MTB) infection than are HIV-uninfected individuals [3,4]. Moreover, the incidence
of active tuberculosis in HIV-infected individuals is inversely proportional to the number of
CD4 T cells in their peripheral blood [5, 6].
In addition to the roles of CD4+ T cells in immune protection against tuberculosis in hu-
mans,M. tuberculosis antigen-specific CD4+ T cells may contribute to immunopathology in
the lungs and other organs [7,8]. Studies have demonstrated that in HIV-infected patients with
active tuberculosis, the frequency of cavitary lung lesions is directly proportional to the number
of peripheral blood CD4 T cells at the time of TB diagnosis [9]. One study revealed that a pre-
dominant Th1 immune response had been observed in non-cavitary tuberculosis patients
while cavitary-involved segments of the lungs accumulated Th2 CD4+ T cell subsets [10]. An-
other study showed that neutrophils were predominant in the bronchoalveolar lavage fluid of
cavitary lesions of tuberculosis [11], which is one of several potential pathogenic mechanisms
including a dominant Th17 response [12].
Th17 cells, a relatively newly-described subset of CD4+ T cells, are implicated in host de-
fense and in autoimmunity. IL-23 or IL-6, in combination with IL-1β, can efficiently induce
IL-17 production in naive precursors, independently of TGF-β [13]. Recent studies showed
that IL-17 contributes to both immune protection and immune pathology of tuberculosis [14,
15]. Some studies had showed that antigen specific IL-17 was involved with immune pathology
in MTB infection. One study found that IL-17A is involved in the formation of mature granu-
loma in the Mycobacterium bovis bacille Calmette-Guérin (BCG)-infected lung [16]. Another
study reported that MTB antigen-specific, IL-17-mediated neutrophil recruitment was directly
related to increased pathological damage in the lung and enhanced pathological consequences
are associated with an IL-17-dominated response and increased tissue involvement [17]. IFN-
γ, mainly produced by CD4+ T cells, plays a critical role in resistance to tuberculosis and is nec-
essary for host survival and optimal long-term protection againstM. tuberculosis [18,19,20].
Our previous study showed that the variation ofM. tuberculosis antigen-specific IFN-γ and
IFN-γ /IL-17 exceeds that of responses to the polyclonal stimulus PHA in TST positive healthy
humans, implying a variation of IFN-γ /IL-17 might be associated with outcome of infection in
patients with active PTB [21]. Cavity is one of the common tuberculous lesions in lungs which
can develop from caseating granulomas [22]. Therefore, we hypothesized that there exists an
imbalance of Th1/Th17 in cavitary PTB: IL-17 might participate in the formation of pulmo-
nary cavities in tuberculosis; immune protection might decrease while immune pathology
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increases in cavitary tuberculosis; and Th1/Th17 in cavitary PTB might be lower than in non-
cavitary PTB. To determine our hypothesis, we quantifiedM. tuberculosis antigen-specific
IFN-γ and IL-17 in peripheral blood and stained PBMCs with anti-human T cell antibody in
patients with active PTB, looking for an association between cavity formation and Th1/Th17
response by T cells.
Materials and Methods
Study population
Subjects were recruited from patients hospitalized at Unit 1 in the Department of Tuberculosis,
Shanghai Pulmonary Hospital between July 1, 2012 and December 31, 2013. Patients were
included in the study if they fulfilled all the following criteria:⑴diagnosed as newly treated ac-
tive PTB confirmed by bacteriology, with all information regarding bacteriology, pathology,
typical radiological manifestation and clinical response to anti-tuberculosis treatment available;
⑵ Tuberculous cavity or non-cavitary lesions in lungs could be observed on chest CT scan;
⑶ patients had never been treated for TB or treatment duration was within one week; and
⑷ subjects provided informed consent for the study. During the same period, healthy volun-
teers were recruited for the control group. All procedures were performed in accord with the
protocol, and this study was confirmed to be approved by the Ethics Committee of Shanghai
Pulmonary Hospital (IRB number 2012017) which is the name of institutional review board in
the hospital, written informed consent was obtained from all participants who signed and
agreed to participate in this study.
All information regarding characteristics of thoracic radiology (diameter in cavity, number
and location of cavities, symptoms, complications, history of BCG vaccination, disseminated
extrapulmonary tuberculosis) was carefully recorded.
Isolation of PBMC and cell culture assays
Venous blood samples (10 mL) were collected in heparin tubes; PBMC (peripheral blood mono-
nuclear cells) were isolated within 3 hours after blood collection. PBMC isolation was performed
by density gradient centrifugation using Ficoll-Hypaque (Axis-shield) following the manufactur-
er’s instructions. After washing the cells, 3x105 cells per well were cultured in 200 μL medium of
RPMI-1640 (GIBCO, Invitrogen) with 10% human serum, penicillin (50 U/mL), streptomycin
(50 μg/mL), 2 mM L-glutamine and 10 mMHEPES using 96-well round-bottom plates (Costar).
PBMC were then stimulated with PHA (phytohemagglutinin, a nonspecific T cell stimulus;
5 ug/ml), PPD (purified protein derivative, 5 μg/mL, Statens Serum Institute, Denmark), recom-
binant ESAT-6 (early secreted antigenic target, 6 kDa ofM. tuberculosis; 10 μg/mL), or medium
alone as a negative control. ESAT-6 was recombinant and kindly provided by the Shanghai Insti-
tute of Immunology, Shanghai JiaoTong University School of Medicine.
Cell staining and flow cytometry
PBMC were incubated with PPD, ESAT-6, PHA or medium alone at 37°C in 5% CO2 for 72
hours. Brefeldin A (eBioscience, BFA, final working concentration 3uL/mL) was added to the
cells 4 hours before staining. Antibodies were prepared, cells transferred to tubes then spun
down at 750 g for 5 minutes at 4°C and washed once in 500 uL FACS buffer. Samples were re-
suspended in 100 uL of diluted antibody against human cell-surface markers (CD4-PerCP-Cy5.5
(eBioscience,USA), CD8-PE/CYTM7 (BD,USA), or CD3-ECD (Beckman Coulter, France)),
incubated for 30 minutes at 4°C, and washed twice in 500 uL FACS buffer. Supernatants were re-
moved and cells were resuspended in 100 uL of Cytofix/Cytoperm(BD,USA), then incubated 20
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minutes at 4°C. After washing cells, cells were suspended in diluted intracellular antibodies
(PE-IL-17 (BD,USA), Alexa Fluor-IFN-γ (BD,USA), PE-isotype (BD,USA) or Alexa Fluor-iso-
type (BD,USA)), incubated 30 minutes at 4°C, then washed in 500uL 1X PermWash and resus-
pended in 100 uL of 1% paraformaldehyde. Data were collected using a BECKMANCOULTER
Cytomics FC 500 Flow Cytometry System and analyzed with CXP software.
Cytokine analyses in culture supernatants by ELISA
Cells were cultured and stimulated with the aforementioned antigens and controls for 24 hours
(for IFN-γ responses) or 72 hours (for IL-17 responses) at 37°C in 5% CO2. Supernatants were
collected and stored at -70°C until the time of assay. The concentration of IFN-γ was deter-
mined using the Human IFN-γ ELISA Set (eBiosciences, USA), after diluting the supernatants
sufficiently to yield results within the linear range of the assay (routine dilutions were: PHA-
stimulated samples, 1:5–1:100; PPD, 1:5–1:10) Supernatants from negative controls or ESAT-6
stimulated samples were not diluted. IL-17 concentrations in supernatants were quantified
using the Human IL-17 ELISA Set (eBioscience, USA) with 72 hours of incubation. Superna-
tants from PHA-stimulated samples were diluted 1:2; all other assays were performed on undi-
luted supernatants. All assays were done in duplicate. Plates were read at 450 nm within 30
minutes of the end of the assay, using an ELISA plate reader.
Statistical analyses
Differences between two groups were calculated by the unpaired, two tailed student’s t-test
using Prism 5.01 software. The graph of severity grade of cavitary pulmonary tuberculosis was
performed by statistical software SPSS 16.0. Values of p< 0.05 were considered
statistically significant.
Results
Patient population
A total of 110 participants including 93 newly treated patients with PTB and 17 healthy control
volunteers joined this study. All patients had their diagnoses confirmed by bacterial culture. 52
Table 1. Demographic Characteristics of 93 PTB patients.
Groups (PTB)
Characteristic Cavitary Non-cavitary P value
52(%) 41(%)
sex (male) 35(67.3) 26(63.4) 0.69
age 41.17±17.11 39.93±17.37 0.23
extrapulmonary tuberuclosis 8(15.4) 8(19.5) 0.60
pleural tuberculosis 2 3
bronchial tuberculosis 4 4
intestinal tuberculosis 1 0
laryngeal tuberculosis 1 0
tuberculous meningitis 0 1
Diabetes 9(17.3) 2(4.9) 0.07
Lesions 4 lung fields 22(42.3) 11(26.8) 0.12
Other complications (COPD, bronchiectasis) 3(5.8) 3(7.3) 0.76
history of BCG vaccination 48(92.3%) 36(87.8%) 0.47
doi:10.1371/journal.pone.0127087.t001
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patients had cavitary lesions on chest CT scanning. Mean age in the cavitary group was 41.2±
17.1 while that in the non-cavitary group was 39.9±17.4. No significant differences existed re-
garding age, sex, frequency of diabetes, history of BCG vaccination and other complications be-
tween the two groups.
Among 17 healthy volunteers, the mean age was 31.1±5.6. Five were excluded from healthy
donors analysis due to their latent TB infection, given that their PBMC produced high levels of
IFN-γ in response to ESAT-6 and positive TST skin test (Tuberculin Skin Test). We separated
the data of five people as latent TB infection group. The data are shown in Table 1.
Similar levels, but large variation of IFN-γ responses in cavitary PTB and
non-cavitary PTB
Among 93 patients with active PTB including both the cavitary and non-cavitary groups, we
observed large variation in IFN-γ responses stimulated by PHA, PPD, ESAT-6 or unstimulated
Fig 1. IFN-γ secretion by ELISA in supernatant of PBMC stimulated with medium (unstimulated, A), PHA(B), PPD(C) or ESAT-6(D). p value refers to
comparison of IFN-γ levels.
doi:10.1371/journal.pone.0127087.g001
Impaired IFN-γResponse in Patients with Severe Cavitary PTB
PLOSONE | DOI:10.1371/journal.pone.0127087 May 27, 2015 5 / 19
control in both active PTB groups (Fig 1). As in our previous study, the degree of variation in
IFN-γ responses to any of the stimuli in PBMCs from patients with active PTB was significant-
ly higher than in those of healthy controls. For example, PPD stimulated IFN-γ secretion ran-
ged from 14540 pg/mL to 2.31 pg/mL in cavitary PTB and from 9353 pg/mL to 3.89 pg/mL in
Fig 2. Shown in scatter diagram: IL-17 secretion tested by ELISA in supernatant of PBMC stimulated with medium (unstimulated, A), PHA (B), PPD
(C) and ESAT-6(D). There were no statistic differences of IL-17 between cavitary and non-cavitary PTB. Fig 2E was showed in histogram: IL-17 secretion in
response to different stimuli among patients with cavity, no cavity and healthy controls.
doi:10.1371/journal.pone.0127087.g002
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non-cavitary PTB, and ESAT-6 stimulated IFN-γ varied over 700-5614-fold range, from
2.68 pg/mL to 15040 pg/mL in cavitary PTB and from 16.32 pg/mL to 11950 pg/mL in non-cavi-
tary PTB. The variation of IFN-γ secretion was similar between cavitary and non-cavitary PTB.
The mean levels of IFN-γ in supernatants of PBMC stimulated with any of the stimuli, and
in unstimulated cells, were also similar between the cavitary and non-cavitary PTB groups.
However, the IFN-γ level in supernatant from healthy controls was significantly lower than
that in either group with active PTB (p<0.05) except that in response to PPD and ESAT-6
from no cavity vs healthy control did not get statistic differences(p>0.05), it might result from
limited number of healthy control group.
Similar levels and variation of IL-17 secretion between cavitary and non-
cavitary PTB
IL-17 secretion between cavitary and non-cavitary PTB groups was similar, p>0.05. In addition,
we found that a wide range of IL-17 secretion existed in both active PTB groups but less variation
as IFN-γ had. IL-17 ranged 1-350-fold in cavitary PTB and 1-110-fold in non-cavitary PTB.
Fig 3. Percentage of IFN-γ secreting CD4+ T cells among cavitary and non-cavitary PTB as well as healthy controls, using cell staining and flow
cytometry. PBMC cultured with unstimulated (A), PHA(B), PPD(C) and ESAT-6(D).
doi:10.1371/journal.pone.0127087.g003
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In supernatant stimulated by ESTA-6 and unstimulated, IL-17 secretions of non- cavitary
PTB groups were significantly higher than those of healthy control group, p< 0.05. In PPD,
ESAT-6 and PHA stimulation, IL-17 of cavitary PTB was slightly higher than that of non-cavi-
tary PTB but there was no statistic significance as showed in Fig 2A–2D and Fig 2E showed the
IL-17 change in different stimuli and different groups, there was no significant difference of IL-
17 between PPD and ESAT-6 stimulation, p> 0.05.
Similar percentages of Mtb antigen-specific IFN-γ and IL-17 producing
CD4+ T cells between cavitary and non-cavitary PTB
We stained cells for identification by flow cytometry, then tested the percentage of IFN-γ
and IL-17 producing CD4+ T cells after cell cultured and stimulated. The data was shown in
Figs 3 and 4. The percentage of IFN-γ producing CD4+ CD3+ cells after stimulation with
PHA, PPD, ESAT-6 and medium alone was significantly higher in both active PTB groups
than in healthy donors, p<0.05. Furthermore, percentages of IFN-γ producing CD4+ CD3
+ cells were similar in cavitary and non-cavitary PTB after any stimulus, percentages of IL-17
producing CD4+ T cells were also similar among cavitary PTB, non-cavitary PTB and healthy
controls(p>0.05) except that of cavity TB under PHA stimulation was higher than that of healthy
donors, p was 0.049.
Fig 4. Percentage of IL-17 secreting CD4+ T cells among cavitary and non-cavitary PTB as well as healthy controls, using cell staining and flow
cytometry. PMBC cultured with unstimulated (A), PHA(B), PPD(C) and ESAT-6(D).
doi:10.1371/journal.pone.0127087.g004
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Mtb antigen-specific IFN-γ expression is decreased in PTB subjects with
severe cavities
Since there were no significant differences in IFN-γ and IL-17 levels or IFN-γ and IL-17 pro-
ducing CD4+ T cells between cavitary and non-cavitary PTB, we looked through all clinical
characteristics of the subjects, then further subdivided the patients according to the diameter
and number of cavities in cavitary PTB group and the field range of TB lesions on the chest
CT in all patients. We discerned two subgroups (see S1–S2 Figs): the first subgroup (the se-
vere cavity PTB group) included 14 cases, in which cavity diameter was > 3 cm or multiple
(>3) cavities. The second subgroup (the mild non-cavity PTB group) included 17 cases, in
which patients had mild lesions ( two lung fields) and had no cavity. The data (Fig 5A–5D)
showed that the IFN-γ produced in response to PHA, PPD, and ESAT-6 in the severe cavity
PTB group was statistically reduced compared with that in the mild lesion non-cavity
PTB group (p values all < 0.05). IFN-γ stimulated by ESAT-6 and PHA in the severe cavity
PTB group was as low as that in healthy controls and latent TB infection group(p>0.05),
Fig 5. IFN-γ secretion measured by ELISA in supernatant of PBMC cultured with unstimulated (A), PHA(B), PPD(C), ESAT-6(D) in severe cavity
PTB group, mild lesion non-cavity PTB group, latent TB infection group and control donors.
doi:10.1371/journal.pone.0127087.g005
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unstimulated IFN-γ level in severe cavity PTB was even significantly lower than that of latent
TB group (p<0.0001), possibly indicating that the IFN-γ-producing T cells are impaired in
the severe cavity group.
Similar Mtb antigen-specific IL-17 and IFN-γ/IL-17 between severe
cavitary PTB and mild non-cavity PTB
Since we found much lower IFN-γ responses in severe cavitary PTB subjects, we compared the
differences of IL-17 responses to all stimuli between severe cavity and mild lesion non-cavity
PTB. We measured similar levels of IL-17 in response to any stimuli between two groups
(p>0.05). There was no significant different imbalance of IFN-γ/IL-17 although IFN-γ re-
sponses was impaired in severe cavity PTB, the data was showed in Fig 6.
Mtb antigen-specific CD3+ percentages are remarkably decreased in
severe cavitary PTB
To further determine the potential reason for decreased IFN-γ in response to PHA and
MTB antigens in severe cavity PTB, we compared the percentages of CD3+, CD3+CD4+, and
Fig 6. IFN-γ/IL-17 measured by ELISA in supernatant of PBMC cultured with unstimulated (A), PHA(B), PPD(C), ESAT-6(D) in severe cavity PTB
group andmild lesion non-cavity PTB groups.
doi:10.1371/journal.pone.0127087.g006
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CD3+CD8+ cells between two groups. The results were shown in Fig 7A–7D: the percentage of
CD3+ cells in the severe cavity PTB group was much lower than in the mild lesion non-cavity
PTB group, p values< 0.05. The plot images of percentages of CD3+ cells in two groups were
shown in Figs 8 and 9. The decreased percentages of CD3+ cells in the severe cavity PTB group
resulted in part from decreased CD3+CD4+ cells, rather than CD3+CD8+ T cells (p
values< 0.05), data was shown in Fig 10A–10D. We also found significantly decreased PPD
specific IFN-γ +CD4+ expression in severe cavity PTB patients (p<0.05). IFN-γ +CD4+ in re-
sponse to ESAT-6 seemed like to be lower in severe cavity PTB but had no significant differ-
ence as shown in Fig 11, p>0.05.
Fig 7. Percentage of CD3+ cells from PBMC after culture with unstimulated (A), PHA(B), PPD(C) or ESAT-6(D) in severe cavity PTB group andmild
lesion non-cavity PTB group.
doi:10.1371/journal.pone.0127087.g007
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IFN-γ response changed and finally decreased with the severe cavity
developed in lung of patient with PTB
We regrouped all the participants according to the severity of cavity and lesions in lungs,
there were five grades for all patients, grade1: healthy control; grade 2: no cavity and lesions2
lung fields; grade 3: had cavity and cavity diameter2cm and lesions 3 lung fields; grade
4: 2 cm< cavity diameter3cm or cavity number< 3 or cavity diameter2cm but lesions> 3
lung fields; grade 5 cavity diameter>3 cm or multiple cavities(cavity number3) with any se-
verity of lung lesions. A total of 70 TB patients and 12 healthy donors were satisfied with above
grading condition. We found that health controls with grade 1 had lower IFN-γ response to
any stimuli, then IFN-γ response increased markedly 12–50 fold in grade 2 of patients with
PTB, IFN-γ declined gradually about 20% in grade 3 and then slightly rose about 30% in grade
4, finally decreased 10–50 fold to be very low level in grade 5 which represented severe cavitary
PTB, the change pattern of IFN-γ with severe cavities of TB was shown in Fig 12 in bar graph
and Fig 13 in line graph.
Fig 8. Plot image of CD3-ECD in flow cytometry in severe cavitary PTB.
doi:10.1371/journal.pone.0127087.g008
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Discussion
This study reported the wide variation ofM. tuberculosis antigen-specific IFN-γ and IL-17 re-
sponses in active PTB patients with the similarity in humans with latent TB infection shown in
our previous study [21]. In the current study,M. tuberculosis antigen-specific IFN-γ and IL-17
in PBMC from patients with active PTB was significantly increased compared to that from
cells of healthy controls or donors (HD). However, we did not find statistic differences of IFN-
γ and IL-17 between cavity and non-cavity PTB groups.
For IL-17 expression in humans, we reviewed several published studies concerning IL-17 se-
cretion in active TB patients. One study [23] reported that the proportion of IL-17 producing
cells among lymphocytes was similar between TB patients and HD, but IL-17 producing cells
in the gamma-delta T cell population were increased in PTB patients. Another study [24]
found thatM. tuberculosis induced IL-17 was markedly augmented in the blood of active PTB
patients; moreover IL-17 expression in lymphocytes was higher in severe pulmonary lesions,
reflecting the severity of lesions in the lungs. One recent study [25] showed that ex vivo PPD
stimulation of PBMCs from patients with PTB did not significantly stimulate IL-17 release;
rather, higher IL-17 was found in patients with infiltrative disease, in comparison with those af-
fected with military and cavitary lesions. Our result implied some trend of increased IL-17
Fig 9. Plot image of CD3-ECD in flow cytometry in mild lesion non-cavity PTB(9).
doi:10.1371/journal.pone.0127087.g009
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secretion in PBMC from cavitary PTB which was partly consistent with the aforementioned
study, although we did not observe a statistical difference between cavity and non-cavity TB.
After staining the cells, we found similar levels of IFN-γ producing CD4+CD3+ cells be-
tween cavity and non-cavity PTB; both groups had statistically higher percentages of IFN-γ
producing CD4 T cells than HD. Through comparison of IL-17 levels in PBMC by ELISA and
producing T cells by flow cytometry, we came to the conclusion that TB antigen-specific IL-17
secretion was not statistically increased in PBMC of active PTB.
Since we did not find any difference of levels in IFN-γ and IL-17 secretion between cavity
and non-cavity PTB, we looked through the detailed data from each patient because so much
individual variation existed. Using chest CT imaging, we defined severe cavitary PTB by the
presence of multiple cavities ( 3) or a cavity diameter of more than 3 cm, while mild non-cav-
itary PTB was defined as non-cavity TB with less than two lung fields of lesions. We found that
IFN-γ in response to PHA and TB antigens in severe cavitary PTB patients was statistically
lower than that in patients with mild lesions of non-cavity PTB. When we further analyzed the
staining data, significantly decreased CD3+ percentage in severe cavitary PTB compared to
that in mild lesion non-cavity PTB also was observed. In addition, the decrease in CD3+ T cells
resulted from a reduction in CD3+CD4+ cells, rather than in CD3+CD8+ cells.
Fig 10. Percentage of CD3+CD4+ cells from PBMC after culture with unstimulated (A), PHA(B), PPD(C) or ESAT-6(D) in severe cavity PTB group
andmild lesion non-cavity PTB group.
doi:10.1371/journal.pone.0127087.g010
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To further elucidate and expose the relationship of IFN-γ response and the severity of cavity
of TB in lungs, we graded the enrolled participants as grade 1–5 according to the severity of
cavity and pulmonary lesions. IFN-γ in response to any stimuli increased dramatically in grade
2 represented PTB subjects compared to the level of grade 1 which represented heathy control,
then slowly went down in grade 3 and slowly went up in grade 4, finally decreased to the very
low level which was almost as low as that in healthy control shown in Fig 10, this figure of
change trend further demonstrated that IFN-γ depression in PBMC of PTB was associated
with cavitary severity of TB, the decreased and very low IFN-γ response will be observed when
PTB develops to severe cavities.
Barry, et al [11] demonstrated impaired antigen-specific CD4+ T lymphocytes in cavitary
tuberculosis, and other studies [26,27] also reported impaired antigen specific IFN-γ in cavitary
tuberculosis, but no one made the stratification analysis for cavitary PTB by number and diam-
eter of cavities, their numbers of participants enrolled were much lower than current study. At
Fig 11. Percentage of IFN-γ+ CD4+ T cells from PBMC after culture with unstimulated (A), PHA(B),PPD(C) or ESAT-6(D) in severe cavity PTB
groups andmild lesion non-cavity PTB group.
doi:10.1371/journal.pone.0127087.g011
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the site of infection, the proliferation reaction and immune response were also weaker in cavi-
tary tuberculosis as reported by two studies [28, 29].
To explain our study results, we postulate several mechanisms to explain the decreased
CD3+ percentage in PBMC of severe cavitary PTB after restimulatioin withM. tb antigens in
vitro. Firstly, CD3+ T cells might manifest weak viability as a decreased percentage of CD3
+ cells, as observed in cultivation with PHA, which is a non-specific polyclonal stimulant of T
cells. Excessive apoptosis might occur in CD3+ T cells during the course of contact between an-
tigens and cells [30], as recent studies showed increased apoptosis in active PTB. Using PD-1
and its ligands as indicators of measurement, a higher percentage of apoptotic T cells and CD4
lymphocytes in children with acute phase central nervous tuberculosis has been observed
[31,32]. Secondly, the decreased percentage of CD3+ T cells might have been due to excess ac-
cumulation of neutrophils in severe cavitary PTB[11,33], because previous studies [34] had
pointed out that accumulation of neutrophils was detrimental to the host and associated with
loss of IFN-γ responsiveness. We did not measure neutrophil numbers in this study so this
possibility needs to be verified in future research. Thirdly, we are not able to tell whether there
are altered immune responses at the site of TB infection because we failed to separate large
numbers of cells from Bronchoalveolar lavage fluid (BALF) of active PTB. BALF might contain
excess IL-17 and neutrophils in severely cavitary PTB, which may have different proportions of
cells compared with mild lesion non-cavity PTB. That was a weakness of this study. We need
Fig 12. Shown in histogram, IFN-γ secretion by ELISA in supernatant of PBMC stimulated with medium (unstimulated, A), PHA(B), PPD(C) or
ESAT-6(D) in five grades of subjects, p value refers to comparison of IFN-γ levels.
doi:10.1371/journal.pone.0127087.g012
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to further measure and analyse additional immune responses (Th1, Th2, Th17, Treg) and in-
teractions between lymphocytes, neutrophils and DC cells. Treg populations would be possibly
involved with the loss of Ag-specific IFN-γ in severe cavities PTB and might also support the
immune disruption that occurs.
In summary, the wide range of IFN-γ in active PTB patients was observed. IFN-γ and IL-17
secretion were similar ex vivo between cavitary PTB and non-cavitary PTB, and IL-17 seemed
to have no association with cavities in blood of active PTB. The IFN-γ response increased
greatly at the mild stage of PTB, then changed with the progress of the lesions and finally
dropped to very low level when lesions make progress to be at stage with severe cavities. We
demonstrate that M.tuberuclosis antigen-specific Th1 response is impaired when PTB lesions
develop to severe cavities.
Supporting Information
S1 Fig. Chest CT image in severe cavitary PTB, large cavity 7.5cm in diameter in left upper
lobe marked by a white arrow.
(TIF)
S2 Fig. Chest CT image in mild lesion non-cavitary PTB, mild lesion without cavity con-
fined to posterior segment of left upper lobe marked by a white arrow.
(TIF)
Fig 13. Shown in line graph, mean IFN-γ concentration in different groups of PBMC cultured with
unstimulated, PHA, PPD and ESAT-6, horizontal axis represents different grades of patients, vertical
axis represents mean IFN-γ secretion of PBMC.Grades represent cavitary severity of TB: 1 healthy
controls; 2 no cavity and lesions2 lung fields; 3 cavity diameter2cm and lesions 3 lung fields; 4 2
cm < cavity diameter3cm or cavity diameter2cm and lesions > 3 lung fields; 5 cavity diameter >3 cm or
multiple cavities(cavity number3).
doi:10.1371/journal.pone.0127087.g013
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